Maharashtra’s food and drug administration noted significant price differences for hospital medical devices. Procurement costs were substantially lower than declared maximum retail prices for many items. The agency has requested central government intervention to examine these pricing discrepancies. Essential medical devices used during inpatient treatment require greater transparency and oversight. This situation highlights regulatory gaps and potential increases in patient healthcare expenditure.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.